HBM Healthcare (Switzerland) Performance

HBMN Stock  CHF 175.60  5.80  3.20%   
The firm retains a Market Volatility (i.e., Beta) of 0.0789, which attests to not very significant fluctuations relative to the market. As returns on the market increase, HBM Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding HBM Healthcare is expected to be smaller as well. At this point, HBM Healthcare Inves has a negative expected return of -0.0815%. Please make sure to check out HBM Healthcare's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if HBM Healthcare Inves performance from the past will be repeated in the future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HBM Healthcare Investments has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, HBM Healthcare is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Begin Period Cash FlowM
Total Cashflows From Investing Activities50 M
  

HBM Healthcare Relative Risk vs. Return Landscape

If you would invest  18,700  in HBM Healthcare Investments on August 25, 2024 and sell it today you would lose (1,140) from holding HBM Healthcare Investments or give up 6.1% of portfolio value over 90 days. HBM Healthcare Investments is generating negative expected returns and assumes 1.7628% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than HBM, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon HBM Healthcare is expected to under-perform the market. In addition to that, the company is 2.29 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

HBM Healthcare Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for HBM Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HBM Healthcare Investments, and traders can use it to determine the average amount a HBM Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0462

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsHBMN

Estimated Market Risk

 1.76
  actual daily
15
85% of assets are more volatile

Expected Return

 -0.08
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average HBM Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HBM Healthcare by adding HBM Healthcare to a well-diversified portfolio.

HBM Healthcare Fundamentals Growth

HBM Stock prices reflect investors' perceptions of the future prospects and financial health of HBM Healthcare, and HBM Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HBM Stock performance.

About HBM Healthcare Performance

Evaluating HBM Healthcare's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if HBM Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HBM Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund exits its portfolio companies through trade sale or IPO. HBM Healthcare operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange.

Things to note about HBM Healthcare Inves performance evaluation

Checking the ongoing alerts about HBM Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HBM Healthcare Inves help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
HBM Healthcare Inves generated a negative expected return over the last 90 days
HBM Healthcare Investments has accumulated 148.92 M in total debt with debt to equity ratio (D/E) of 12.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. HBM Healthcare Inves has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HBM Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, HBM Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HBM Healthcare Inves sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HBM to invest in growth at high rates of return. When we think about HBM Healthcare's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (78.03 M) with loss before overhead, payroll, taxes, and interest of (73.78 M).
HBM Healthcare Investments has accumulated about 5.39 M in cash with (10.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Roughly 17.0% of HBM Healthcare shares are held by company insiders
Evaluating HBM Healthcare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate HBM Healthcare's stock performance include:
  • Analyzing HBM Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HBM Healthcare's stock is overvalued or undervalued compared to its peers.
  • Examining HBM Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating HBM Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HBM Healthcare's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of HBM Healthcare's stock. These opinions can provide insight into HBM Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating HBM Healthcare's stock performance is not an exact science, and many factors can impact HBM Healthcare's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for HBM Stock Analysis

When running HBM Healthcare's price analysis, check to measure HBM Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HBM Healthcare is operating at the current time. Most of HBM Healthcare's value examination focuses on studying past and present price action to predict the probability of HBM Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HBM Healthcare's price. Additionally, you may evaluate how the addition of HBM Healthcare to your portfolios can decrease your overall portfolio volatility.